India, April 16 -- Harbour BioMed (2142.HK,HBMHF), a biopharmaceutical company, on Thursday announced the appointment of Adam Zong as its new President.
Zong brings more than 20 years of global biopharma leadership experience.
Zong joins from Arc Nouvel Clinical Development Consulting where he served as Principal Consultant
On the Hongkong Stock Exchange, shares of Harbour closed Thursday's regular trading 2.14 percent higher at HK$14.790
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....